Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    11823931 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)
Condition: Post-operative Excessive Scarring
Interventions: Drug: Botulinum Toxin;   Drug: Saline
2 Recruiting Improvement of the Appearance of Cleft Lip Scars Using Botox
Conditions: Cleft Lip;   Scarring;   Cleft Palate
Interventions: Drug: Botulinum Toxin Type A;   Drug: Normal Saline Injection
3 Unknown  Botulinum Toxin to Improve Results in Cleft Lip Repair
Condition: Scar
Interventions: Drug: Botulinum Toxin Type A;   Drug: Botulinum Type A;   Drug: Normal Saline

Study has passed its completion date and status has not been verified in more than two years.